STEMI (ST-Elevation Myocardial Infarction) is a critical medical emergency characterized by complete blockage of a coronary artery, leading to extensive, transmural (full-thickness) heart muscle damage. The “ST-elevation” refers to a specific pattern on an electrocardiogram (ECG) where the ST segment is abnormally elevated above the baseline, indicating acute, ongoing myocardial injury.
Pathophysiology: The “Widow-Maker” Mechanism
A STEMI typically occurs when an atherosclerotic plaque in a coronary artery ruptures, triggering:
- Platelet aggregation and thrombus formation
- Complete occlusion of the artery
- Cessation of blood flow to downstream myocardium
- Irreversible necrosis beginning within 20-30 minutes
- Wavefront phenomenon – cell death spreads from endocardium to epicardium
Clinical Presentation: The Classic Triad
Symptoms:
- Severe, crushing chest pain (≥20 minutes duration)
- Radiation to left arm, jaw, neck, or back
- Associated symptoms: Dyspnea, nausea/vomiting, diaphoresis (cold sweats), anxiety, syncope
- Atypical presentations: More common in women, diabetics, and elderly (may present with fatigue, indigestion, or silent MI)
Physical Findings:
- Tachycardia or bradycardia
- Hypotension or hypertension
- Pulmonary edema (crackles on auscultation)
- New mitral regurgitation murmur (papillary muscle dysfunction)
- Fourth heart sound (S4)
Diagnostic Criteria
1. Electrocardiogram (ECG) – The Definitive Tool
STEMI is diagnosed when ALL of the following are present:
- ST-segment elevation ≥1 mm in two contiguous leads
- New left bundle branch block (LBBB) with typical symptoms
- Posterior STEMI patterns: Dominant R wave and ST depression in V1-V3
Location-Based ECG Patterns:
- Anterior STEMI: V1-V4 (proximal LAD occlusion)
- Inferior STEMI: II, III, aVF (RCA or LCx occlusion)
- Lateral STEMI: I, aVL, V5-V6
- Posterior STEMI: Tall R waves + ST depression V1-V3
2. Cardiac Biomarkers
- Troponin I/T: Gold standard – rises within 3-4 hours, peaks at 24 hours
- CK-MB: Less specific, but useful for detecting reinfarction
- Point-of-care testing for rapid diagnosis
3. Additional Imaging
- Echocardiography: Assess wall motion abnormalities, complications
- Coronary angiography: Definitive anatomic diagnosis during PCI
Time-Critical Management: “Time is Muscle”
Immediate Actions (First 10 Minutes):
- MONA protocol (though modern protocols have evolved):
- Morphine (for pain refractory to nitrates)
- Oxygen (if SpO₂ <90%)
- Nitroglycerin (sublingual, if BP >90 mmHg systolic)
- Aspirin (162-325 mg chewable)
- Dual Antiplatelet Therapy (DAPT):
- Aspirin (162-325 mg loading dose)
- P2Y₁₂ inhibitor: Ticagrelor 180mg or Clopidogrel 600mg or Prasugrel 60mg
- Anticoagulation:
- Unfractionated heparin or Enoxaparin or Bivalirudin
Reperfusion Therapy: The 90-Minute Door-to-Balloon Goal
Primary Percutaneous Coronary Intervention (PCI):
- First-line treatment if available within 120 minutes
- Mechanical thrombectomy often used
- Stent placement (drug-eluting preferred)
Fibrinolytic Therapy:
- Indications: PCI unavailable within 120 minutes
- Contraindications: Absolute (active bleeding, aortic dissection) and relative
- Agents: Alteplase, Reteplase, Tenecteplase
- Rescue PCI if fibrinolysis fails
Complications: The Cascade of Danger
Early Complications (Hours to Days):
- Arrhythmias: Ventricular fibrillation, ventricular tachycardia, bradycardia
- Cardiogenic shock (mortality ~50%)
- Mechanical complications:
- Ventricular septal rupture (days 3-5)
- Papillary muscle rupture causing acute MR
- Free wall rupture (often fatal)
- Pericarditis (Dressler’s syndrome: weeks later)
Late Complications:
- Left ventricular aneurysm formation
- Heart failure (systolic dysfunction)
- Recurrent ischemia/MI
- Sudden cardiac death
Post-STEMI Care & Secondary Prevention
Hospital Phase:
- Coronary care unit (CCU) monitoring
- Beta-blockers (within 24 hours if stable)
- ACE inhibitors/ARBs (within 24 hours)
- High-intensity statin therapy
- Aldosterone antagonists if EF ≤40% with symptoms
Long-Term Management:
- Lifelong DAPT (duration depends on stent type)
- Cardiac rehabilitation (reduces mortality by 20-30%)
- Risk factor modification: Smoking cessation, BP control, diabetes management
- ICD consideration if EF ≤35% at 40 days post-MI
Prognosis & Statistics
- Mortality: 5-6% in-hospital; 7-18% at 1 year
- Key predictors: Age, Killip class, time to reperfusion, infarct size
- “Golden Hour”: Mortality increases 7.5% for each 30-minute delay in reperfusion
- 30% of patients develop heart failure within 10 years
Special Populations
Women:
- Present later, with more atypical symptoms
- Higher mortality, more complications
- Underrepresented in clinical trials
Diabetics:
- Silent MIs more common
- Worse outcomes, higher mortality
- More diffuse coronary disease
Young Patients (<45 years):
- Often have single-vessel disease
- Better prognosis with aggressive intervention
- Substance abuse (cocaine) as potential trigger
ICD-10 Coding
- I21.0-I21.3: Based on anatomical location (anterior, inferior, etc.)
- I21.4: Non-ST elevation myocardial infarction (NSTEMI)
- I22.-: Subsequent STEMI within 28 days
The Future of STEMI Care
- Pre-hospital ECG transmission
- Regional STEMI networks for rapid transfer
- Pharmacoinvasive strategy (lytics + early PCI)
- Remote ischemic conditioning
- Stem cell therapy research
Critical Takeaway: STEMI represents the most severe form of acute coronary syndrome where every minute counts. The paradigm is “time equals myocardium” – rapid recognition, immediate ECG, and urgent reperfusion (ideally via primary PCI within 90 minutes) are paramount to saving lives and preserving cardiac function. The chain of survival depends on integrated systems of care from pre-hospital recognition to long-term secondary prevention.
This response is AI-generated, for reference only.